ALEXION PHARMACEUTICALS, INC.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1992-01-01
- Employees
- 3.8K
- Market Cap
- -
- Website
- http://www.alexion.com
Atypical Hemolytic-Uremic Syndrome (aHUS) Registry
- Conditions
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 3000
- Registration Number
- NCT01522183
- Locations
- 🇬🇧
Clinical Trial Site, Wales, United Kingdom
🇪🇸Clinical Trial Site 1, Barcelona, Spain
🇪🇸Clinical Trial Site 2, Barcelona, Spain
Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of SBC-102 (Sebelipase Alfa) in Adult Subjects With Lysosomal Acid Lipase Deficiency
- Conditions
- Interventions
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01488097
Study to Evaluate Safety, Tolerability, PK and PD of ALXN1007 in Healthy Subjects
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01454986
- Locations
- 🇺🇸
PAREXEL Baltimore EPCU, Baltimore, Maryland, United States
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)
- Conditions
- First Posted Date
- 2011-08-17
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01419028
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Indiana University school of medicine, Indianapolis, Indiana, United States
🇺🇸Shriners Hospital for Children, Saint Louis, Missouri, United States
Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study
- Conditions
- First Posted Date
- 2011-08-08
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT01412047
- Locations
- 🇩🇪
Universitatsklinikum Essen, Essen, Germany
🇩🇪Institut fur Klinische Transfusionmedizin und Immungenetick, Ulm, Germany
🇮🇹Azienda Ospediliera Universitatia Careggi, Firenze, Italy
Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
- Conditions
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2013-04-05
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT01410916
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
- First Posted Date
- 2011-07-22
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01399593
Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry
- Conditions
- First Posted Date
- 2011-06-16
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 5950
- Registration Number
- NCT01374360
- Locations
- 🇺🇸
Contact the PNH Registry at Alexion Pharmaceuticals, Inc. for worldwide locations., Boston, Massachusetts, United States
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Sebelipase Alfa in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency
- Conditions
- Interventions
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT01371825
A Retrospective Natural History Study of Patients With Lysosomal Acid Lipase Deficiency/Wolman Phenotype
- Conditions
- First Posted Date
- 2011-05-23
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01358370
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸Cedars-Siani Medical Center, Los Angeles, California, United States
🇺🇸Columbia University, New York, New York, United States